• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Ajjarapu J. Ram

    4/8/26 5:45:59 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care
    Get the next $XAGE alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Ajjarapu J. Ram

    (Last)(First)(Middle)
    2403 SIDNEY STREET, SUITE 300

    (Street)
    PITTSBURGH PENNSYLVANIA 15203

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/16/2026
    3. Issuer Name and Ticker or Trading Symbol
    Longevity Health Holdings, Inc. [ XAGE ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirectorX10% Owner
    XOfficer (give title below)Other (specify below)
    Chief Executive Officer
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock689,656IBy International Capital Partners LLC(1)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
    /s/ J. Ram Ajjarapu04/08/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $XAGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XAGE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XAGE
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Longevity Health Holdings Inc.

    SCHEDULE 13D - Longevity Health Holdings, Inc. (0001842939) (Subject)

    4/8/26 9:52:46 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    SEC Form 424B3 filed by Longevity Health Holdings Inc.

    424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

    3/31/26 4:35:12 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Longevity Health Holdings Inc.

    10-K - Longevity Health Holdings, Inc. (0001842939) (Filer)

    3/31/26 4:30:30 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    $XAGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth

    PITTSBURGH, March 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling businesses and executing value-creating transactions," said Rajiv Shukla, outgoing Chairman and Chief Executive Officer. "We look forward to his leadership as Longevity seeks to advance its growth strategy through acquisitions as a public company." "I am excited to join Longevity and help build the Company's acquisition platform," said Mr. Ajjarapu. "My investment and leadership commitme

    3/17/26 8:30:00 AM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

    PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ:XAGE), a company focused on human longevity and healthy aging ("Longevity", the "Company", "we", "our", or "us"), today announced the execution of a definitive merger agreement (the "Merger") with True Health Inc., a leading player in the fast growing plasma collection industry under the THPlasma brand ("THPlasma"), to combine the companies in an all-stock transaction. Following the closing of the Merger (the "Closing"), the combined company is expected to continue to trade on Nasdaq under the symbol "XAGE." Longevity today also announced the mutual termination of the 20/20 BioLabs transaction purs

    7/14/25 4:30:00 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale

    Pittsburgh, PA, May 27, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ:XAGE) ("XAGE," the "Company," "we" or "our"), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition, today announced the successful sale of 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering facility. Gross proceeds from the ATM sales totaled approximately $1.96 million, prior to deducting fees and expenses.  Assuming no growth beyond the Company's pro forma consolidated FY24 sales and not factoring in the planned 20/20 merger, this financing extends XAGE'

    5/27/25 9:20:00 AM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    $XAGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ajjarapu J. Ram

    4 - Longevity Health Holdings, Inc. (0001842939) (Issuer)

    4/8/26 5:47:11 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Ajjarapu J. Ram

    3 - Longevity Health Holdings, Inc. (0001842939) (Issuer)

    4/8/26 5:45:59 PM ET
    $XAGE
    Medical/Dental Instruments
    Health Care

    $XAGE
    Leadership Updates

    Live Leadership Updates

    View All

    Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth

    PITTSBURGH, March 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling businesses and executing value-creating transactions," said Rajiv Shukla, outgoing Chairman and Chief Executive Officer. "We look forward to his leadership as Longevity seeks to advance its growth strategy through acquisitions as a public company." "I am excited to join Longevity and help build the Company's acquisition platform," said Mr. Ajjarapu. "My investment and leadership commitme

    3/17/26 8:30:00 AM ET
    $XAGE
    Medical/Dental Instruments
    Health Care